Keywords: Ang-II; angiotensin-II; CDKs; cyclin-dependent kinases; ChGn; chondroitin N-acetylgalactosaminyltransferase; ChPF; chondroitin polymerizing factor; ChSy; chondroitin synthase; CS; chondroitin sulfate; CVDs; cardiovascular diseases; C4S; chondroitin-4-sulf
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: glycosaminoglycans; bioanalysis; processing; LC-MS; NMR spectroscopy; molecular weight determination; heparin; enoxaparin; bovine lung; porcine intestine; ATIII; antithrombin III; BLE; bovine lung heparin-derived enoxaparin; ESI; electrospray ionization
Keywords: GAG; glycosaminoglycan; GlcA; d-glucuronic acid; GlcA2SO3; d-glucuronic acid 2-sulfate; GlcN; d-glucosamine; GlcNSO36SO3; d-glucosamine N,6-sulfated; IdoA; l-iduronic acid; IdoA2SO3; l-iduronic acid 2-sulfate; TSD; trisulfated disaccharide; AT; antithromb
Keywords: Neu5Ac; N-acetylneuraminic acid; Neu5Gc; N-glycolylneuraminic acid; Gal; galactose; GalNAc; N-acetylgalactosamine; GlcNAc; N-acetylglucoseamine; Man; mannose; Fuc; fucose; GlcA; glucoronic acid; IdoA; iduronic acid; Xyl; xylose; Personalized-medicine; Sia
Characterization of epimerization and composition of heparin and dalteparin using a UHPLC-ESI-MS/MS method
Keywords: HONO; nitrous acid; IdoA; iduronic acid; GlcA; glucuronic acid; GlcN; glucosamine; SAX; strong anion exchange; RP-IP; reverse phase ion pairing; HILIC; hydrophilic interaction chromatography; WAX; weak anion exchange; LMWHs; low molecular weight heparins;
Structural analysis and biological activity of a highly regular glycosaminoglycan from Achatina fulica
Keywords: GAG; glycosaminoglycan; LMWH; low-molecular-weight heparin; DS; dermatan sulfate; TSP; trimethylsilyl-propionic acid; GlcA; glucuronic acid; GlcNAc; N-acetyl-2-deoxy-2-amino-glucose; IdoA; iduronic acid; IdoA2S; 2-sulfated iduronic acid; Mw; molecular wei
Increased deposition of glycosaminoglycans and altered structure of heparan sulfate in idiopathic pulmonary fibrosis
Keywords: IPF; idiopathic pulmonary fibrosis; ECM; extracellular matrix; GAG; glycosaminoglycan; HS; heparan sulfate; CS; chondroitin sulfate; DS; dermatan sulfate; HA; hyaluronan; UA; uronic acid; GlcA; glucuronic acid; IdoA; iduronic acid; GalNAc; N-acetyl-d-gala
Structural Analysis of Heparin-Derived 3-O-Sulfated Tetrasaccharides: Antithrombin Binding Site Variants
Keywords: antithrombin-binding site; heparin-derived tetrasaccharides; anticoagulant activity; heparin lyase; structure-activity relationship; AT; antithrombin III; UA; uronic acid; IdoA; iduronic acid; GlcA; β-D-glucuronic acid; GlcN; α-d-glucosamine; STs; sulfo
Establishment of chondroitin B lyase-based analytical methods for sensitive and quantitative detection of dermatan sulfate in heparin
Keywords: ChonB; chondroitin B lyase; CP; Chinese Pharmacopoeia; CS; chondroitin sulfate; DS; dermatan sulfate; E.coli; Escherishchia coli; EP; European Pharmacopoeia; GAG; glycosaminoglycan; GalNAc4S; 4-O-sulfo-α-d-N-acetylgalactosamine; GlcNS6S; 6-O-sulfo-N-sulf
Controllable production of low molecular weight heparins by combinations of heparinase I/II/III
Keywords: HIT; heparin-induced thrombocytopenia; LMWHs; low molecular weight heparins; HepI; heparinase I; HepII; heparinase II; HepIII; heparinase III; GlcNS6S; 6-O-sulfo-N-sulfo-α-d-glucosamine; GlcNS3S6S; 3,6-di-O-sulfo-N-sulfo-α-d-glucosamine; IdoA2S; 2-O-sul
Cooperation of binding sites at the hydrophilic domain of cell-surface sulfatase Sulf1 allows for dynamic interaction of the enzyme with its substrate heparan sulfate
Keywords: AFM; atomic force microscopy; CS; chondroitin sulfate; DMMB; 1,9-dimethylmethylene blue; DS; dermatan sulfate; DSMFS; dynamic SMFS; ECM; extracellular matrix; FGF; fibroblast growth factor; GAG; glycosaminoglycan; GlcA; glucuronic acid; GlcNAc; N-acetylgl
Structural characterisation of chondroitin sulphate from Italian cheese Parmigiano-Reggiano
Keywords: CS; chondroitin sulphate; DS; dermatan sulphate; EULAR; The European League Against Rheumatism; GAG(s); glycosaminoglycan(s); GalN; galactosamine; GlcNAc; N-acetylglucosamine; GlcA; glucuronic acid; GlcN; glucosamine; HA; hyaluronic acid or hyaluronan; He
Structural characterisation of oligosaccharides obtained by Fenton-type radical depolymerisation of dermatan sulfate
Keywords: GAGs; glycosaminoglycans; LMWH; low molecular weight heparin; DS; dermatan sulfate; GalNAc4S; N-acetylgalactosamine; IdoA; iduronic Acid; ÎU; Î4,5 unsaturated uronic acid; HSQC; Heteronuclear single quantum coherence; TOCSY; Total correlation spectrosco
Asparagine 405 of heparin lyase II prevents the cleavage of glycosidic linkages proximate to a 3-O-sulfoglucosamine residue
Keywords: HS; heparan sulfate; GlcA; glucuronic acid; IdoA; iduronic acid; GlcNS6S; 6-O-sulfo-N-sulfoglucosamine; GlcNAc6S; 6-O-sulfo-N-acetylglucosamine; GlcNS3S6S; 3,6-O-sulfo-N-sulfoglucosamine; AT; antithrombin; Hep; heparin lyase; PAGE; polyacrylamide gel elec
Depiction of the forces participating in the 2-O-sulfo-α-l-iduronic acid conformational preference in heparin sequences in aqueous solutions
Keywords: Heparin; Molecular dynamics; Polysaccharide; IdoA; Iduronic acid
Syndecans in wound healing, inflammation and vascular biology
Keywords: Aβ; amyloid β protein; AD; Alzheimer's disease; AT-III; antithrombin-III; CAA; cerebral amyloid angiopathy; CS; chondroitin sulphate; EB; embryoid body; ECM; extracellular matrix; EGF; epidermal growth factor; ES cells; embryonic stem cells; FGF; fibrob
Quantitative proteomic analysis of fibroblast nuclear proteins after stimulation with mitogen activated protein kinase inhibiting heparan sulfate
Keywords: Cell growth; Fibroblast; Heparan sulfate; Mitogen-activated protein kinase (MAP kinase); Signal transduction; bFGF; basic fibroblast growth factor; CS; chondroitin sulfate; DS; dermatan sulfate; DexS; dextran sulfate; EGF; epidermal growth factor; EMEM; E